These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 23904584)

  • 1. Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered.
    Dye C
    J R Soc Interface; 2013 Oct; 10(87):20130365. PubMed ID: 23904584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Bacillus Calmette-Guerin revaccination necessary for Japanese children?
    Rahman M; Sekimoto M; Hira K; Koyama H; Imanaka Y; Fukui T
    Prev Med; 2002 Jul; 35(1):70-7. PubMed ID: 12079443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting.
    Fu H; Lin HH; Hallett TB; Arinaminpathy N
    Vaccine; 2018 Sep; 36(39):5902-5909. PubMed ID: 30143270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review protocol on Bacillus Calmette-Guerin (BCG) revaccination and protection against tuberculosis.
    Mahasha PW; Ndwandwe DE; Mavundza EJ; Shey M; Wiysonge CS
    BMJ Open; 2019 Oct; 9(10):e027033. PubMed ID: 31619416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adults.
    Hatherill M; Geldenhuys H; Pienaar B; Suliman S; Chheng P; Debanne SM; Hoft DF; Boom WH; Hanekom WA; Johnson JL
    Vaccine; 2014 Jun; 32(31):3982-8. PubMed ID: 24814553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01
    Clark RA; Weerasuriya CK; Portnoy A; Mukandavire C; Quaife M; Bakker R; Scarponi D; Harris RC; Rade K; Mattoo SK; Tumu D; Menzies NA; White RG
    BMC Med; 2023 Aug; 21(1):288. PubMed ID: 37542319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cost-effectiveness analysis of universal versus selective immunization with Mycobacterium bovis bacille Calmette-Guérin in Finland.
    Hersh AL; Tala-Heikkilä M; Tala E; Tosteson AN; Fordham von Reyn C
    Int J Tuberc Lung Dis; 2003 Jan; 7(1):22-9. PubMed ID: 12701831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong.
    Leung CC; Tam CM; Chan SL; Chan-Yeung M; Chan CK; Chang KC
    Int J Tuberc Lung Dis; 2001 Aug; 5(8):717-23. PubMed ID: 11495262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
    Nemes E; Geldenhuys H; Rozot V; Rutkowski KT; Ratangee F; Bilek N; Mabwe S; Makhethe L; Erasmus M; Toefy A; Mulenga H; Hanekom WA; Self SG; Bekker LG; Ryall R; Gurunathan S; DiazGranados CA; Andersen P; Kromann I; Evans T; Ellis RD; Landry B; Hokey DA; Hopkins R; Ginsberg AM; Scriba TJ; Hatherill M;
    N Engl J Med; 2018 Jul; 379(2):138-149. PubMed ID: 29996082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [BCG vaccines for the prevention of tuberculosis in the world].
    Hashimoto T
    Kekkaku; 1997 Nov; 72(11):629-37. PubMed ID: 9423301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting the Chingleput BCG vaccination trial for the impact of BCG revaccination on the incidence of tuberculosis disease.
    Velayutham B; Thiruvengadam K; Kumaran PP; Watson B; Rajendran K; Padmapriyadarsini C
    Indian J Med Res; 2023; 157(2&3):152-159. PubMed ID: 36124494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Where do we stand with BCG vaccination programme in Japan?].
    Mori T
    Kekkaku; 2001 Apr; 76(4):385-97. PubMed ID: 11398330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling the health and economic impacts ofM72/AS01
    Sumner T; Clark RA; Mukandavire C; Portnoy A; Weerasuriya CK; Bakker R; Scarponi D; Hatherill M; Menzies NA; White RG
    Vaccine; 2024 Feb; 42(6):1311-1318. PubMed ID: 38307747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of universal BCG vaccination of Japanese infants.
    Rahman M; Sekimoto M; Takamatsu I; Hira K; Shimbo T; Toyoshima K; Fukui T
    Int J Epidemiol; 2001 Apr; 30(2):380-5. PubMed ID: 11369746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacillus Calmette-Guérin revaccination questionable with low tuberculosis incidence.
    Tala-Heikkilä MM; Tuominen JE; Tala EO
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1324-7. PubMed ID: 9563757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
    Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
    Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health economic evaluation of current vaccination strategies and new vaccines against tuberculosis: a systematic review.
    Machlaurin A; Pol SV; Setiawan D; van der Werf TS; Postma MJ
    Expert Rev Vaccines; 2019 Sep; 18(9):897-911. PubMed ID: 31369299
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential cost-effectiveness of a new infant tuberculosis vaccine in South Africa--implications for clinical trials: a decision analysis.
    Ditkowsky JB; Schwartzman K
    PLoS One; 2014; 9(1):e83526. PubMed ID: 24454706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCG vaccination in India and tuberculosis in children: newer facets.
    Udani PM
    Indian J Pediatr; 1994; 61(5):451-62. PubMed ID: 7744445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the bacille Calmette-Guérin vaccination for the prevention of tuberculosis: renewed interest in an old vaccine.
    Cohn DL
    Am J Med Sci; 1997 Jun; 313(6):372-6. PubMed ID: 9186153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.